PolarityTE (PTEIQ) Competitors

$0.07
0.00 (0.00%)
(As of 05/14/2024 ET)

PTEIQ vs. PKBO, ATHX, AMPE, CALA, IGNY, MOTS, OBSV, SMFL, APVO, and SXTC

Should you be buying PolarityTE stock or one of its competitors? The main competitors of PolarityTE include Peak Bio (PKBO), Athersys (ATHX), Ampio Pharmaceuticals (AMPE), Calithera Biosciences (CALA), Ignyte Acquisition (IGNY), Motus GI (MOTS), ObsEva (OBSV), Smart for Life (SMFL), Aptevo Therapeutics (APVO), and China SXT Pharmaceuticals (SXTC). These companies are all part of the "medical" sector.

PolarityTE vs.

Peak Bio (NASDAQ:PKBO) and PolarityTE (NASDAQ:PTEIQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, community ranking, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Peak Bio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
PolarityTE
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, PolarityTE's average media sentiment score of 0.00 equaled Peak Bio'saverage media sentiment score.

Company Overall Sentiment
Peak Bio Neutral
PolarityTE Neutral

11.8% of PolarityTE shares are held by institutional investors. 19.9% of Peak Bio shares are held by company insiders. Comparatively, 5.4% of PolarityTE shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

PolarityTE has higher revenue and earnings than Peak Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Peak Bio$610K0.32-$13.09MN/AN/A
PolarityTE$810K0.63-$7.83M-$3.28-0.02

PolarityTE's return on equity of 0.00% beat Peak Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Peak BioN/A N/A N/A
PolarityTE N/A -106.08%-76.91%

Peak Bio has a beta of 0.12, indicating that its stock price is 88% less volatile than the S&P 500. Comparatively, PolarityTE has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Peak Bio received 1 more outperform votes than PolarityTE when rated by MarketBeat users.

CompanyUnderperformOutperform
Peak BioOutperform Votes
1
100.00%
Underperform Votes
No Votes
PolarityTEN/AN/A

Summary

PolarityTE beats Peak Bio on 5 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTEIQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTEIQ vs. The Competition

MetricPolarityTEBiotechnology IndustryMedical SectorNASDAQ Exchange
Market Cap$512,000.00$164.54M$5.08B$7.95B
Dividend YieldN/A3.43%36.92%3.93%
P/E Ratio-0.02253.96139.9315.77
Price / Sales0.6315,050.642,314.2380.15
Price / CashN/A11.3435.5631.30
Price / Book0.036.345.494.47
Net Income-$7.83M-$15.03M$104.35M$216.49M
7 Day PerformanceN/A0.82%1.27%2.05%
1 Month PerformanceN/A5.31%2.74%4.39%
1 Year PerformanceN/A3.77%6.12%10.56%

PolarityTE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PKBO
Peak Bio
0 of 5 stars
$0.01
flat
N/A-98.9%$192,000.00$610,000.000.0021High Trading Volume
ATHX
Athersys
0 of 5 stars
$0.00
flat
N/A-99.4%$265,000.00$146,000.000.0024Analyst Forecast
News Coverage
Gap Down
AMPE
Ampio Pharmaceuticals
0 of 5 stars
$0.26
flat
N/A-94.1%$291,000.00N/A-0.026Analyst Forecast
News Coverage
Gap Down
CALA
Calithera Biosciences
0 of 5 stars
$0.02
flat
N/A-23.4%$97,000.00$9.75M0.008
IGNY
Ignyte Acquisition
0 of 5 stars
$0.01
flat
N/A-98.9%$62,000.00N/A0.00N/A
MOTS
Motus GI
1.376 of 5 stars
$0.07
flat
$28.88
+40,004.2%
-99.2%$362,000.00$319,000.000.0015News Coverage
Gap Down
OBSV
ObsEva
0 of 5 stars
$0.01
flat
N/AN/A$390,000.00$20.11M-0.0148Analyst Forecast
News Coverage
SMFL
Smart for Life
0 of 5 stars
$3.58
+7.8%
N/A-98.1%$394,000.00$17.77M0.00145Gap Up
APVO
Aptevo Therapeutics
0.3559 of 5 stars
$0.99
-12.4%
N/A-98.8%$425,000.00$3.11M0.0040Analyst Revision
News Coverage
SXTC
China SXT Pharmaceuticals
0 of 5 stars
$0.96
-4.9%
N/A-79.9%$439,000.00$1.70M0.0078

Related Companies and Tools

This page (NASDAQ:PTEIQ) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners